Aarti Drugs (BOM:524348) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524348 Aarti Drugs Ltd BOM:524348
65 GF Score
Price ₹404.65
GF Value ₹498.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Aarti Drugs Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:524348 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aarti Drugs Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Short Interest distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Short Interest falls into.


BOM:524348
65GF Score
Aarti Drugs Ltd BOM:524348
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aarti Drugs (BOM:524348) Overvalued in 2026?

Based on GuruFocus' analysis, Aarti Drugs stock appears to be undervalued. The current stock price of ₹404.65 is trading 18.9% below its estimated GF Value™ of ₹498.91. GuruFocus considers Aarti Drugs to be Modestly Undervalued.

Key valuation signals for BOM:524348:

  • Short Interest:
  • GF Value™: ₹498.91 vs. price of ₹404.65 (18.9% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the BOM:524348 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aarti Drugs Business Description

Other Exchanges AARTIDRUGS:India
Address Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.
65GF Score

Get the complete analysis for BOM:524348

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹404.65
Price
₹498.91
GF Value